deucravacitinib
bms
[' psa', 'deucra']
#spa posters #acr22 2132. safety of deucravacitinib, oral selective tyk2i ph2 trial in psa &amp; 2 ph3 trials in pso effects on hematological, hepatic, cpk &amp; cholesterol lab parameters characteristic of jaki 1/2/3 were generally not observed over 16 wks #acrambassador 
Rheumatologist | Epi | ASAS | Twitter Ambassador (ACR/ ARD-BMJ) | ArLAR ARCH President | St Joseph University & HDF Beirut | Love Music | Travel Books